Panacea Biotec share price

ABOUT Panacea Biotec

• Industry Biotechnology & Drugs
• ISIN INE922B01023
• BSE Code 531349
• NSE Code PANACEABIO

Panacea Biotec Limited is an India-based pharmaceutical and biotechnology company with research, manufacturing and marketing capabilities. The Company is engaged in the business of research, development, manufacture and marketing of branded vaccines, pharmaceutical formulations, nutraceuticals and food and nutrition products in India and international markets. Its segments include vaccines and formulations. It has specialized in the development of fully liquid combination vaccines that can be stored at 2-8 degree Celsius temperature. Its vaccine portfolio includes EasySix (DTwP-Hib-HepB-IPV), EasyFive-TITM (DTwP-Hib-HepB), EasyFour-TI (DTwP-Hib), EasyFourPol (DTwP-IPV) and Bivalent oral polio vaccine (type-1 and type-3). Its pipeline vaccines include NucoVac 11, DengiALL and Td (tetanus and diphtheria - reduced). Its pharmaceutical formulation products include Sitcom Tablets and Sitcom Cream. Its nutrition product brand names include ChilRunfull, ChilRun 7+ and ChilRun NoSucrose.

Panacea Biotec Management

• Vinod Goel Group Chief Financial Officer, Compliance Officer, Company Secretary, Head - Legal
• Devender Gupta Chief Financial Officer, Head - Information Technology
• Rajesh Jain Managing Director, Executive Director
• Sandeep Jain Joint Managing Director, Executive Director
• Ankesh Jain Executive Director, Director - Sales and Marketing